Back
Structure Therapeutics Stock Price Chart
Sponsored
GPCR
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
75
GPCR
Structure Therapeutics
Last Price:
41.85
Seasonality Move:
81.19%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.
Structure Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.79 | Buy |
20-day SMA: | 38.84 | Buy |
50-day SMA: | 38.09 | Buy |
200-day SMA: | 41.19 | Buy |
8-day EMA: | 39.46 | Buy |
20-day EMA: | 38.8 | Buy |
50-day EMA: | 38.8 | Buy |
200-day EMA: | 39.63 | Buy |
Structure Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.47 | Buy |
Relative Strength Index (14 RSI): | 60.54 | Buy |
Chaikin Money Flow: | 569776 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.22 - 40.62) | Buy |
Bollinger Bands (100): | (34.7 - 45.08) | Buy |
Structure Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 41.92 while GPCR 8-day simple moving average is 39.79, which is a Buy signal.
- The stock price of GPCR is 41.92 while Structure Therapeutics 20-day SMA is 38.84, which makes it a Buy.
- Structure Therapeutics 50-day simple moving average is 38.09 while GPCR share price is 41.92, making it a Buy technically.
- GPCR stock price is 41.92 and Structure Therapeutics 200-day simple moving average is 41.19, creating a Buy signal.
GPCR Technical Analysis vs Fundamental Analysis
Buy
75
Structure Therapeutics (GPCR)
is a Buy
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a Buy
The current Structure Therapeutics [GPCR] share price is $41.92. The Score for GPCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
Structure Therapeutics Stock Info
Market Cap:
2.4B
Price in USD:
41.92
Share Volume:
1.15M
Structure Therapeutics 52-Week Range
52-Week High:
75.02
52-Week Low:
26.61
Buy
75
Structure Therapeutics (GPCR)
is a Buy
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?
The Structure Therapeutics stock price is 41.92 USD today. -
Will GPCR stock go up or go down?
Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Structure Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is not overvalued.
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 41.92 while GPCR 8-day exponential moving average is 39.46, which is a Buy signal.
- The stock price of GPCR is 41.92 while Structure Therapeutics 20-day EMA is 38.80, which makes it a Buy.
- Structure Therapeutics 50-day exponential moving average is 38.80 while GPCR share price is 41.92, making it a Buy technically.
- GPCR stock price is 41.92 and Structure Therapeutics 200-day simple moving average is 39.63, creating a Buy signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.08 per share, and an increase next year of $0.08 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
- GPCR Moving Average Covergence Divergence (MACD) indicator is 0.47, suggesting Structure Therapeutics is a Buy
- Structure Therapeutics Relative Strength Index (RSI) is 60.54, which suggest Structure Therapeutics is overbought
- The Bollinger Bands (25) for Structure Therapeutics is (37.22 - 40.62), which suggest Structure Therapeutics is a Buy
- The Bollinger Bands (100) for Structure Therapeutics is (34.7 - 45.08), which suggest Structure Therapeutics is a Buy
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.